Division of Metabolism and Children's Research Center, University Children's Hospital, Steinwiesstrasse 75, CH-8032 Zürich, Switzerland.
Mol Genet Metab. 2012 Apr;105(4):602-6. doi: 10.1016/j.ymgme.2011.12.018. Epub 2011 Dec 31.
Isolated 3-Methylcrotonyl-CoA carboxylase deficiency (MCC deficiency) is an organic aciduria presenting with a highly variable phenotype and has been part of newborn screening programs in various countries, in particular in the US. Here we present enzymatic and genetic characterisation of 22 individuals with increased 3-hydroxyisovalerylcarnitine and/or 3-methylcrotonylglycine suggesting MCC deficiency, but only partially reduced 3-methylcrotonyl-CoA carboxylase activity. Among these, 21 carried a single mutant allele in either MCCC1 (n=20) or MCCC2 (n=1). Our results suggest that heterozygosity for such a single deleterious mutation may lead to misdiagnosis of MCC deficiency.
孤立的 3-甲基戊二酰辅酶 A 羧化酶缺乏症(MCC 缺乏症)是一种有机酸尿症,表现出高度可变的表型,已成为许多国家新生儿筛查项目的一部分,特别是在美国。在这里,我们对 22 名 3-羟基异戊酰肉碱和/或 3-甲基戊烯酰甘氨酸升高的个体进行了酶和基因特征分析,提示存在 MCC 缺乏症,但 3-甲基戊二酰辅酶 A 羧化酶活性仅部分降低。其中,21 人在 MCCC1(n=20)或 MCCC2(n=1)中携带单一突变等位基因。我们的研究结果表明,这种单一有害突变的杂合性可能导致 MCC 缺乏症的误诊。